Results 101 to 110 of about 17,785 (168)

Fractionation gives therapeutic benefit in animal model of [¹⁷⁷Lu]Lu-PSMA-617 therapy of prostate cancer. [PDF]

EJNMMI Res
Timmermand OV, Östholm A, Zedan W, Strand J, Altai M, Örbom A.   +5 more
europepmc   +1 more source

PSMA PET-guided intensification of postprostatectomy salvage radiotherapy for prostate cancer: a systematic review and meta-analysis. [PDF]

Front Oncol
Liu G, Shu Y, Hong J, Li Z, Yang X.
europepmc   +1 more source

False-positive PSMA uptake from urinary reflux into a seminal vesicle cyst in renal agenesis. [PDF]

Radiol Case Rep
Ting CH, Singh D, Yaxley J.
europepmc   +1 more source

Investigating the Theranostic Potential of Elementally Matched [⁴³Sc]Sc-PSMA-617 and [⁴⁷Sc]Sc-PSMA-617. [PDF]

Mol Pharm
Cingoranelli SJ, Putnam E, Houson HA, Gimblet GR, Samuel S, Tekin V, Lapi SE.   +6 more
europepmc   +1 more source

Theranostics in Sarcoma: A Critical Review of Current Evidence and Future Potential. [PDF]

Curr Treat Options Oncol
Appana O, Konieczkowski D, Tinoco G.
europepmc   +1 more source

Prognostic value of tumour volume based on [¹⁸F]PSMA-1007 PET/CT in prostate cancer. [PDF]

EJNMMI Rep
Ingvar J, Wittgren J, Sverrisdottir V, Trägårdh E, Bjartell A.   +4 more
europepmc   +1 more source

Cost-Effectiveness of PSMA PET/CT as Single Procedure for Diagnosis and Staging High-Grade Prostate Cancer: A Single Center Experience. [PDF]

In Vivo
Pepe P, Pepe L, Pepe G, Privitera R.
europepmc   +1 more source

The role of Choline-PET/CT in patients with recurrent prostate cancer and a negative PSMA-PET/CT. [PDF]

EJNMMI Rep
Gözlügöl N, Bosbach WA, Shelan M, Sari H, Bucher A, Burger IA, Strobel K, Afshar-Oromieh A.   +7 more
europepmc   +1 more source

Incidental detection of PDAC via ¹⁸F-PSMA PET/CT in a patient with recurrent prostate cancer. A case report. [PDF]

Front Nucl Med
Savelli G, Bonacina M, Soffientini A, Archiati E, Bnà C, Zaniboni A.   +5 more
europepmc   +1 more source

Comparison of urinary bladder activity from [⁶⁸Ga]Ga-PSMA-11 and [¹⁸F]PSMA-1007 in patients with prostate cancer undergoing PSMA-ligand PET/CT. [PDF]

EJNMMI Rep
Krieger K, Cumming P, Alberts IL, Rominger AO, Afshar-Oromieh A.   +4 more
europepmc   +1 more source